The University of Chicago Header Logo

Connection

Kenneth Gordon to Interferon Type I

Back to Details
This is a "connection" page, showing publications Kenneth Gordon has written about Interferon Type I.
Kenneth Gordon
Connection Strength
0.048
Interferon Type I
  1. Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis. J Allergy Clin Immunol. 2022 06; 149(6):2010-2020.e8.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.